Glow-in-the-Dark dye could help surgeons remove all cancer

NCT ID NCT04752137

First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 27 times

Summary

This study tests whether a special dye called indocyanine green (ICG) can help surgeons see tumor edges more clearly during bone or soft tissue mass removal. About 100 adults having surgery at Massachusetts General Hospital will receive the dye, and doctors will compare how well it identifies leftover cancer cells versus standard methods. The goal is to reduce the chance of cancer coming back in the same spot.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.